# OnCo record interius (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/interius/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "interius" ;
  schema:name "Interius BioTherapeutics"@en ;
  schema:description "Penn spin-out that dosed the first patient ever with a durable in vivo CAR gene therapy (INT2104, CD20) in the INVISE trial."@en ;
  schema:url <https://onco.cc/companies/interius/>, <https://interiusbio.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://interiusbio.com/press-release/interius-biotherapeutics-doses-first-patient-with-in-vivo-chimeric-antigen-receptor-car-gene-therapy-for-b-cell-malignancies/> ;
  onco:tag "frontier" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:institutions <https://onco.cc/institutions/penn-abramson/> .